Difference between revisions of "GAMIAN-Europe"
| Line 5: | Line 5: | ||
==Notes== | ==Notes== | ||
<references/> | <references/> | ||
| + | |||
| + | [[Category:Patient Groups]] | ||
Latest revision as of 08:00, 22 October 2007
The Guardian reports:
- The Global Alliance of Mental Illness Advocacy Networks was founded by the drug company Bristol Myers Squibb in March 1997, bringing together 12 organisations including Depression Alliance from the UK. GAMIAN-Europe, registered in Belgium, does not detail its funding on its website, apart from acknowledging drug company grants for specific projects. It told the Guardian that nearly half (45%) of its €234,000 (£160,000) income in 2006 came from Eli Lilly, manufacturers of Prozac. Other antidepressant makers also contributed. Lundbeck sponsorship was 26% of the group's income, Pfizer 11%, GlaxoSmithKline 6% and Wyeth 1%. Just 2% came from membership subscriptions.[1]
Notes
- ↑ Sarah Boseley, health editor Drug firms and patient groups join in fight to overturn advertising ban Monday May 21, 2007 The Guardian
